Hanna-Mari Tervo
Overview
Explore the profile of Hanna-Mari Tervo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tervo H, Homann S, Ambiel I, Fritz J, Fackler O, Keppler O
Retrovirology
. 2011 Feb;
8:9.
PMID: 21310048
Background: The cellular transmembrane protein CD317/BST-2/HM1.24/Tetherin restricts HIV-1 infection by physically tethering mature virions to the surface of infected cells. HIV-1 counteracts this restriction by expressing the accessory protein Vpu,...
2.
Tervo H, Keppler O
J Virol
. 2010 Sep;
84(23):12300-14.
PMID: 20861260
An immunocompetent, permissive, small-animal model would be valuable for the study of human immunodeficiency virus type 1 (HIV-1) pathogenesis and for the testing of drug and vaccine candidates. However, the...
3.
Muller B, Anders M, Akiyama H, Welsch S, Glass B, Nikovics K, et al.
J Biol Chem
. 2009 Aug;
284(43):29692-703.
PMID: 19666477
Protease inhibitors (PI) act by blocking human immunodeficiency virus (HIV) polyprotein processing, but there is no direct quantitative correlation between the degree of impairment of Gag processing and virion infectivity...
4.
Seckert C, Renzaho A, Tervo H, Krause C, Deegen P, Kuhnapfel B, et al.
J Virol
. 2009 Jun;
83(17):8869-84.
PMID: 19535440
Latent cytomegalovirus (CMV) is frequently transmitted by organ transplantation, and its reactivation under conditions of immunosuppressive prophylaxis against graft rejection by host-versus-graft disease bears a risk of graft failure due...
5.
Goffinet C, Allespach I, Homann S, Tervo H, Habermann A, Rupp D, et al.
Cell Host Microbe
. 2009 Mar;
5(3):285-97.
PMID: 19286137
Mammals encode proteins that inhibit viral replication at the cellular level. In turn, certain viruses have evolved genes that can functionally counteract these intrinsic restrictions. Human CD317 (BST-2/HM1.24/tetherin) is a...
6.
Tervo H, Goffinet C, Keppler O
Retrovirology
. 2008 Jul;
5:58.
PMID: 18611257
Background: The development of an immunocompetent, genetically modified mouse model to study HIV-1 pathogenesis and to test antiviral strategies has been hampered by the fact that cells from native mice...
7.
Tervo H, Allespach I, Keppler O
J Immunol Methods
. 2008 May;
336(1):85-9.
PMID: 18471825
Efficient gene delivery is essential for the assessment of transgene function in untransformed hematopoietic cells. Here, we explored the utility of different non-viral and viral gene delivery techniques for primary...
8.
Goffinet C, Michel N, Allespach I, Tervo H, Hermann V, Krausslich H, et al.
Retrovirology
. 2007 Jul;
4:53.
PMID: 17655755
Background: In vivo studies on HIV-1 pathogenesis and testing of antiviral strategies have been hampered by the lack of an immunocompetent small animal model that is highly susceptible to HIV-1...
9.
Simon C, Holtappels R, Tervo H, Bohm V, Daubner T, Oehrlein-Karpi S, et al.
J Virol
. 2006 Aug;
80(21):10436-56.
PMID: 16928768
During murine cytomegalovirus (mCMV) latency in the lungs, most of the viral genomes are transcriptionally silent at the major immediate-early locus, but rare and stochastic episodes of desilencing lead to...